nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCB1—colon cancer	0.385	1	CbGaD
Amprenavir—ABCC1—Irinotecan—colon cancer	0.105	0.185	CbGbCtD
Amprenavir—ABCC1—Vincristine—colon cancer	0.0922	0.162	CbGbCtD
Amprenavir—ABCC1—Methotrexate—colon cancer	0.0558	0.098	CbGbCtD
Amprenavir—CYP2B6—Irinotecan—colon cancer	0.0496	0.0871	CbGbCtD
Amprenavir—CYP2C9—Capecitabine—colon cancer	0.0425	0.0745	CbGbCtD
Amprenavir—CYP3A5—Irinotecan—colon cancer	0.0391	0.0686	CbGbCtD
Amprenavir—CYP2C8—Fluorouracil—colon cancer	0.0361	0.0633	CbGbCtD
Amprenavir—CYP3A5—Vincristine—colon cancer	0.0342	0.06	CbGbCtD
Amprenavir—ABCB1—Irinotecan—colon cancer	0.0255	0.0447	CbGbCtD
Amprenavir—CYP2C9—Fluorouracil—colon cancer	0.0252	0.0442	CbGbCtD
Amprenavir—ABCB1—Vincristine—colon cancer	0.0222	0.039	CbGbCtD
Amprenavir—CYP3A4—Irinotecan—colon cancer	0.0153	0.0268	CbGbCtD
Amprenavir—ABCB1—Methotrexate—colon cancer	0.0135	0.0236	CbGbCtD
Amprenavir—CYP3A4—Vincristine—colon cancer	0.0133	0.0234	CbGbCtD
Amprenavir—Gastrointestinal symptom NOS—Fluorouracil—colon cancer	0.00143	0.0316	CcSEcCtD
Amprenavir—Paraesthesia oral—Capecitabine—colon cancer	0.00126	0.0277	CcSEcCtD
Amprenavir—Opportunistic infection—Methotrexate—colon cancer	0.00109	0.024	CcSEcCtD
Amprenavir—Hypertriglyceridaemia—Capecitabine—colon cancer	0.00103	0.0226	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Irinotecan—colon cancer	0.000968	0.0213	CcSEcCtD
Amprenavir—Blood triglycerides increased—Capecitabine—colon cancer	0.000899	0.0198	CcSEcCtD
Amprenavir—Inflammation—Fluorouracil—colon cancer	0.000869	0.0191	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Capecitabine—colon cancer	0.000648	0.0143	CcSEcCtD
Amprenavir—Inflammation—Capecitabine—colon cancer	0.000608	0.0134	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Vincristine—colon cancer	0.000591	0.013	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Irinotecan—colon cancer	0.000576	0.0127	CcSEcCtD
Amprenavir—Neutropenia—Vincristine—colon cancer	0.00053	0.0117	CcSEcCtD
Amprenavir—Neutropenia—Irinotecan—colon cancer	0.000517	0.0114	CcSEcCtD
Amprenavir—Depression—Vincristine—colon cancer	0.000504	0.0111	CcSEcCtD
Amprenavir—Acute coronary syndrome—Vincristine—colon cancer	0.000499	0.011	CcSEcCtD
Amprenavir—Myocardial infarction—Vincristine—colon cancer	0.000496	0.0109	CcSEcCtD
Amprenavir—Sleep disorder—Capecitabine—colon cancer	0.000494	0.0109	CcSEcCtD
Amprenavir—Diabetes mellitus—Capecitabine—colon cancer	0.000492	0.0108	CcSEcCtD
Amprenavir—Acute coronary syndrome—Irinotecan—colon cancer	0.000486	0.0107	CcSEcCtD
Amprenavir—Myocardial infarction—Irinotecan—colon cancer	0.000483	0.0106	CcSEcCtD
Amprenavir—Hyperbilirubinaemia—Methotrexate—colon cancer	0.000482	0.0106	CcSEcCtD
Amprenavir—Acute coronary syndrome—Fluorouracil—colon cancer	0.000465	0.0102	CcSEcCtD
Amprenavir—Myocardial infarction—Fluorouracil—colon cancer	0.000462	0.0102	CcSEcCtD
Amprenavir—Inflammation—Methotrexate—colon cancer	0.000452	0.00995	CcSEcCtD
Amprenavir—Connective tissue disorder—Vincristine—colon cancer	0.000446	0.00982	CcSEcCtD
Amprenavir—Connective tissue disorder—Irinotecan—colon cancer	0.000435	0.00956	CcSEcCtD
Amprenavir—Cardiac disorder—Vincristine—colon cancer	0.000421	0.00927	CcSEcCtD
Amprenavir—Cardiac disorder—Irinotecan—colon cancer	0.00041	0.00903	CcSEcCtD
Amprenavir—Mental disorder—Vincristine—colon cancer	0.000398	0.00875	CcSEcCtD
Amprenavir—Liver function test abnormal—Capecitabine—colon cancer	0.000395	0.00869	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Capecitabine—colon cancer	0.000385	0.00848	CcSEcCtD
Amprenavir—Flatulence—Irinotecan—colon cancer	0.000379	0.00835	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Capecitabine—colon cancer	0.000377	0.0083	CcSEcCtD
Amprenavir—Diabetes mellitus—Methotrexate—colon cancer	0.000366	0.00806	CcSEcCtD
Amprenavir—Abdominal discomfort—Capecitabine—colon cancer	0.000354	0.0078	CcSEcCtD
Amprenavir—Neutropenia—Capecitabine—colon cancer	0.000346	0.00761	CcSEcCtD
Amprenavir—Myalgia—Vincristine—colon cancer	0.000336	0.0074	CcSEcCtD
Amprenavir—Hyperglycaemia—Capecitabine—colon cancer	0.000334	0.00734	CcSEcCtD
Amprenavir—Depression—Capecitabine—colon cancer	0.000329	0.00723	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Capecitabine—colon cancer	0.000327	0.00719	CcSEcCtD
Amprenavir—Acute coronary syndrome—Capecitabine—colon cancer	0.000325	0.00715	CcSEcCtD
Amprenavir—Discomfort—Irinotecan—colon cancer	0.000324	0.00712	CcSEcCtD
Amprenavir—Myocardial infarction—Capecitabine—colon cancer	0.000323	0.00711	CcSEcCtD
Amprenavir—Nervous system disorder—Vincristine—colon cancer	0.000316	0.00696	CcSEcCtD
Amprenavir—Myalgia—Fluorouracil—colon cancer	0.000314	0.00691	CcSEcCtD
Amprenavir—Hepatobiliary disease—Capecitabine—colon cancer	0.000312	0.00686	CcSEcCtD
Amprenavir—Discomfort—Fluorouracil—colon cancer	0.00031	0.00682	CcSEcCtD
Amprenavir—Nervous system disorder—Irinotecan—colon cancer	0.000308	0.00678	CcSEcCtD
Amprenavir—Anorexia—Vincristine—colon cancer	0.000307	0.00677	CcSEcCtD
Amprenavir—Anorexia—Irinotecan—colon cancer	0.000299	0.00659	CcSEcCtD
Amprenavir—Nervous system disorder—Fluorouracil—colon cancer	0.000295	0.00649	CcSEcCtD
Amprenavir—Liver function test abnormal—Methotrexate—colon cancer	0.000294	0.00647	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Vincristine—colon cancer	0.000294	0.00647	CcSEcCtD
Amprenavir—Connective tissue disorder—Capecitabine—colon cancer	0.000291	0.0064	CcSEcCtD
Amprenavir—Paraesthesia—Vincristine—colon cancer	0.00029	0.00637	CcSEcCtD
Amprenavir—Anorexia—Fluorouracil—colon cancer	0.000287	0.00631	CcSEcCtD
Amprenavir—Paraesthesia—Irinotecan—colon cancer	0.000282	0.00621	CcSEcCtD
Amprenavir—Decreased appetite—Vincristine—colon cancer	0.00028	0.00617	CcSEcCtD
Amprenavir—Erythema multiforme—Capecitabine—colon cancer	0.00028	0.00616	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Vincristine—colon cancer	0.000278	0.00613	CcSEcCtD
Amprenavir—Fatigue—Vincristine—colon cancer	0.000278	0.00612	CcSEcCtD
Amprenavir—Cardiac disorder—Capecitabine—colon cancer	0.000275	0.00604	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000274	0.00603	CcSEcCtD
Amprenavir—Decreased appetite—Irinotecan—colon cancer	0.000273	0.00601	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Irinotecan—colon cancer	0.000271	0.00597	CcSEcCtD
Amprenavir—Fatigue—Irinotecan—colon cancer	0.000271	0.00596	CcSEcCtD
Amprenavir—Paraesthesia—Fluorouracil—colon cancer	0.00027	0.00594	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—colon cancer	0.000264	0.00581	CcSEcCtD
Amprenavir—Gastrointestinal pain—Vincristine—colon cancer	0.000264	0.0058	CcSEcCtD
Amprenavir—Decreased appetite—Fluorouracil—colon cancer	0.000262	0.00576	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00026	0.00572	CcSEcCtD
Amprenavir—Mental disorder—Capecitabine—colon cancer	0.000259	0.00571	CcSEcCtD
Amprenavir—Malnutrition—Capecitabine—colon cancer	0.000258	0.00567	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—colon cancer	0.000257	0.00566	CcSEcCtD
Amprenavir—Gastrointestinal pain—Irinotecan—colon cancer	0.000257	0.00565	CcSEcCtD
Amprenavir—Abdominal pain—Vincristine—colon cancer	0.000255	0.00561	CcSEcCtD
Amprenavir—Flatulence—Capecitabine—colon cancer	0.000254	0.00559	CcSEcCtD
Amprenavir—Abdominal pain—Irinotecan—colon cancer	0.000248	0.00546	CcSEcCtD
Amprenavir—Depression—Methotrexate—colon cancer	0.000245	0.00538	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000243	0.00535	CcSEcCtD
Amprenavir—Tremor—Capecitabine—colon cancer	0.000241	0.00531	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—colon cancer	0.000232	0.00511	CcSEcCtD
Amprenavir—Asthenia—Vincristine—colon cancer	0.000231	0.00509	CcSEcCtD
Amprenavir—Asthenia—Irinotecan—colon cancer	0.000225	0.00496	CcSEcCtD
Amprenavir—Diarrhoea—Vincristine—colon cancer	0.000221	0.00486	CcSEcCtD
Amprenavir—Myalgia—Capecitabine—colon cancer	0.000219	0.00483	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000218	0.00479	CcSEcCtD
Amprenavir—Discomfort—Capecitabine—colon cancer	0.000217	0.00477	CcSEcCtD
Amprenavir—Diarrhoea—Irinotecan—colon cancer	0.000215	0.00473	CcSEcCtD
Amprenavir—Pruritus—Fluorouracil—colon cancer	0.000213	0.00468	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—colon cancer	0.000208	0.00458	CcSEcCtD
Amprenavir—Nervous system disorder—Capecitabine—colon cancer	0.000206	0.00454	CcSEcCtD
Amprenavir—Diarrhoea—Fluorouracil—colon cancer	0.000206	0.00453	CcSEcCtD
Amprenavir—Vomiting—Vincristine—colon cancer	0.000205	0.00451	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—colon cancer	0.000204	0.0045	CcSEcCtD
Amprenavir—Skin disorder—Capecitabine—colon cancer	0.000204	0.00449	CcSEcCtD
Amprenavir—Rash—Vincristine—colon cancer	0.000203	0.00448	CcSEcCtD
Amprenavir—Dermatitis—Vincristine—colon cancer	0.000203	0.00447	CcSEcCtD
Amprenavir—Headache—Vincristine—colon cancer	0.000202	0.00445	CcSEcCtD
Amprenavir—Anorexia—Capecitabine—colon cancer	0.0002	0.00441	CcSEcCtD
Amprenavir—Vomiting—Irinotecan—colon cancer	0.0002	0.0044	CcSEcCtD
Amprenavir—Rash—Irinotecan—colon cancer	0.000198	0.00436	CcSEcCtD
Amprenavir—Dermatitis—Irinotecan—colon cancer	0.000198	0.00435	CcSEcCtD
Amprenavir—Headache—Irinotecan—colon cancer	0.000197	0.00433	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—colon cancer	0.000193	0.00425	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—colon cancer	0.000192	0.00422	CcSEcCtD
Amprenavir—Nausea—Vincristine—colon cancer	0.000192	0.00422	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000192	0.00422	CcSEcCtD
Amprenavir—Vomiting—Fluorouracil—colon cancer	0.000191	0.00421	CcSEcCtD
Amprenavir—Rash—Fluorouracil—colon cancer	0.00019	0.00417	CcSEcCtD
Amprenavir—Dermatitis—Fluorouracil—colon cancer	0.00019	0.00417	CcSEcCtD
Amprenavir—Paraesthesia—Capecitabine—colon cancer	0.000189	0.00415	CcSEcCtD
Amprenavir—Headache—Fluorouracil—colon cancer	0.000188	0.00415	CcSEcCtD
Amprenavir—Nausea—Irinotecan—colon cancer	0.000187	0.00411	CcSEcCtD
Amprenavir—Decreased appetite—Capecitabine—colon cancer	0.000183	0.00402	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Capecitabine—colon cancer	0.000182	0.00399	CcSEcCtD
Amprenavir—Fatigue—Capecitabine—colon cancer	0.000181	0.00399	CcSEcCtD
Amprenavir—Nausea—Fluorouracil—colon cancer	0.000179	0.00393	CcSEcCtD
Amprenavir—Gastrointestinal pain—Capecitabine—colon cancer	0.000172	0.00378	CcSEcCtD
Amprenavir—Abdominal pain—Capecitabine—colon cancer	0.000166	0.00366	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—colon cancer	0.000163	0.00359	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000162	0.00357	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—colon cancer	0.000161	0.00355	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—colon cancer	0.000153	0.00338	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—colon cancer	0.000152	0.00335	CcSEcCtD
Amprenavir—Asthenia—Capecitabine—colon cancer	0.000151	0.00332	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—colon cancer	0.000149	0.00328	CcSEcCtD
Amprenavir—Pruritus—Capecitabine—colon cancer	0.000149	0.00327	CcSEcCtD
Amprenavir—Diarrhoea—Capecitabine—colon cancer	0.000144	0.00317	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000143	0.00314	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—colon cancer	0.000141	0.00309	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—colon cancer	0.000136	0.00299	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—colon cancer	0.000135	0.00297	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—colon cancer	0.000135	0.00297	CcSEcCtD
Amprenavir—Vomiting—Capecitabine—colon cancer	0.000134	0.00294	CcSEcCtD
Amprenavir—Rash—Capecitabine—colon cancer	0.000133	0.00292	CcSEcCtD
Amprenavir—Dermatitis—Capecitabine—colon cancer	0.000132	0.00291	CcSEcCtD
Amprenavir—Headache—Capecitabine—colon cancer	0.000132	0.0029	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—colon cancer	0.000128	0.00282	CcSEcCtD
Amprenavir—Nausea—Capecitabine—colon cancer	0.000125	0.00275	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—colon cancer	0.000124	0.00272	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—colon cancer	0.000112	0.00247	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—colon cancer	0.000111	0.00244	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—colon cancer	0.000107	0.00236	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—colon cancer	9.95e-05	0.00219	CcSEcCtD
Amprenavir—Rash—Methotrexate—colon cancer	9.87e-05	0.00217	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—colon cancer	9.86e-05	0.00217	CcSEcCtD
Amprenavir—Headache—Methotrexate—colon cancer	9.81e-05	0.00216	CcSEcCtD
Amprenavir—Nausea—Methotrexate—colon cancer	9.3e-05	0.00205	CcSEcCtD
